Yungjin Pharm Co Ltd 003520
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 2,055.00
- Day Range
- KRW 2,025.00–2,080.00
- 52-Week Range
- KRW 1,960.00–3,085.00
- Bid/Ask
- KRW 2,065.00 / KRW 2,070.00
- Market Cap
- KRW 379.50 Bil
- Volume/Avg
- 124,031 / 375,554
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.62
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Yungjin Pharm Co Ltd is a Korean pharmaceutical company. It manufactures and sales pharmaceutical goods in domestic and overseas markets. The firm's products are cephalosporin antibiotic, antipsychotic, cardiovascular, total nutrition, etc. It has manufacturing facilities located in Jenjou, Namyang, and Iksan in Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 604
- Website
- http://www.yungjin.co.kr
Comparables
Valuation
|
Metric
|
003520
|
140410
|
293480
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 10.26 |
Price/Book Value | 4.23 | 22.10 | 0.83 |
Price/Sales | 1.62 | 34.26 | 1.03 |
Price/Cash Flow | 26.05 | — | 7.58 |
Price/Earnings
003520
140410
293480
Financial Strength
|
Metric
|
003520
|
140410
|
293480
|
|---|---|---|---|
Quick Ratio | 0.86 | 2.17 | 0.93 |
Current Ratio | 1.69 | 2.51 | 1.82 |
Interest Coverage | −0.37 | −43.24 | — |
Quick Ratio
003520
140410
293480
Profitability
|
Metric
|
003520
|
140410
|
293480
|
|---|---|---|---|
Return on Assets (Normalized) | −0.31% | −17.65% | 6.72% |
Return on Equity (Normalized) | −0.73% | −33.91% | 8.59% |
Return on Invested Capital (Normalized) | 1.56% | −28.13% | 7.47% |
Return on Assets
003520
140410
293480
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Kmjzppytnf | Kty | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Ttsslysljz | Lmsrltl | $68.4 Bil | |
HLN
| Haleon PLC ADR | Zqvldxkx | Cmr | $37.0 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Ljbjnmsl | Kvp | $14.5 Bil | |
VTRS
| Viatris Inc | Fvynskd | Mpbvn | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qltxxtj | Vcqz | $12.0 Bil | |
CTLT
| Catalent Inc | Kjzqjldj | Gbzvsck | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Njfskcg | Xvl | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Xzrghfg | Ywvy | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vdmcfzjcb | Rcptflz | $3.5 Bil |